Which has the lower trailing P/E, GMED or PODD?

GMED has the lower trailing P/E: GMED trades at 20.74 and PODD at 27.69. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, GMED or PODD?

Over the past five years, GMED grew revenue faster — GMED at a 27.65% CAGR versus PODD at 25.13%.

Is GMED or PODD more profitable?

GMED runs the higher net margin — GMED at 17.03% versus PODD at 12.29%.

How have GMED and PODD total returns compared?

Over the past 10 years, GMED delivered 12.90% and PODD delivered 13.14% annualized total return. Past performance doesn't predict future results.

Globus Medical, Inc. (GMED) vs Insulet Corp. (PODD)

A side-by-side comparison of Globus Medical, Inc. and Insulet Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 3, 2026. Differences are shown without an overall score or investment verdict.

GMED

Globus Medical, Inc.

$10.54B

$78.12HealthcareDelayed quote: Sep 3, 2026, 4:00 PM EDT

PODD

Insulet Corp.

$10.43B

$150.58HealthcareDelayed quote: Sep 3, 2026, 4:00 PM EDT

Total return — GMED vs PODD

growth of $100 · dividends reinvested · last 10y

GMED +232.5% (+12.8%/yr)PODD +237.5% (+12.9%/yr)PODD compounded faster over this window

GMED PODD

GMED vs PODD: by the numbers

•GMED is the larger company ($10.54B vs $10.43B market cap).
•GMED trades at the lower trailing earnings multiple (20.74 vs 27.69 P/E), one valuation lens rather than an overall verdict.
•GMED converts more revenue to profit (17.03% vs 12.29% net margin).
•GMED grew revenue faster over the past five years (27.65% vs 25.13% CAGR).

Metrics side by side

Valuation

Metric	GMED	PODD
P/E ratio	20.74	27.69
Forward P/E	16.13	22.78
P/S ratio	3.54	3.37
P/B ratio	2.34	7.23
EV / EBITDA	11.52	17.21
FCF yield	6.73%	2.90%

Profitability

Metric	GMED	PODD
Gross margin	68.55%	71.08%
Operating margin	20.75%	16.89%
Net margin	17.03%	12.29%
ROE	11.23%	26.39%
ROIC	10.49%	16.04%

Growth (annualized)

Metric	GMED	PODD
Revenue CAGR (5Y)	27.65%	25.13%
EPS CAGR (5Y)	30.79%	99.91%
FCF CAGR (5Y)	29.93%	N/A
Total return CAGR (5Y)	-0.76%	-13.26%

Frequently asked

Which has the lower trailing P/E, GMED or PODD?: GMED has the lower trailing P/E: GMED trades at 20.74 and PODD at 27.69. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, GMED or PODD?: Over the past five years, GMED grew revenue faster — GMED at a 27.65% CAGR versus PODD at 25.13%.
Is GMED or PODD more profitable?: GMED runs the higher net margin — GMED at 17.03% versus PODD at 12.29%.
How have GMED and PODD total returns compared?: Over the past 10 years, GMED delivered 12.90% and PODD delivered 13.14% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GMED analysis Full PODD analysis Interactive comparison tool

Dig into the metrics

Globus Medical P/E ratio Insulet P/E ratio Globus Medical ROE Insulet ROE Globus Medical operating margin Insulet operating margin Globus Medical revenue growth Insulet revenue growth Globus Medical free cash flow Insulet free cash flow

Globus Medical & Insulet appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 3, 2026.